Objective To analyze the application effect of pharmacists' participation in the maintenance and manage-ment of smart pharmaceutical platform.Methods The prescriptions of Shunde Hospital of Guangzhou University of Chinese Med-icine from January 2023 to June 2024 were divided into blank group(from January 2023 to March 2023,305 411 traditional man-ual prescriptions were reviewed)and control group(from January 2024 to March 2024).The original rule review of the smart pharmacy platform system was adopted,339 042 copies),and the experimental group(from April 2024 to June 2024,the rule review after pharmacists participated in maintenance management was adopted,317 902 copies).The prescription qualification rate,the proportion of unreasonable prescriptions,the false positive rate,the proportion of manual review prescriptions,and the rate of filling prescriptions were evaluated,and the management effectiveness of the three groups was compared.Results The qualified rate of prescription in the experimental group and the control group was 99.52％ and 99.60％,respectively,which were higher than 98.74％ in the blank group,and there was a difference between the experimental group and the control group(P＜0.05).Among the irrational prescription types in the experimental group,the proportion of unsuitable administration route,in-complete clinical diagnosis,unsuitable indications and unsuitable usage and dosage were 16.57％,29.42％,20.55％ and 33.46％,and 23.28％,15.74％,30.38％ and 30.50％ in the control group.There were significant differences between 40.08％,27.11％,19.91％ and 12.9％ in blank group(P＜0.05).The false positive rate and manual prescription review ra-tio of the experimental group were 0.40％ and 0.88％,respectively,lower than 0.70％and 1.10％of the control group,and the prescription return rate of 0.78％ was higher than 0.10％ of the control group(P＜0.05).Conclusion Pharmacists' par-ticipation in the maintenance and management of smart pharmacy platform has high application value and can improve the drug safety of patients.

Objective To analyze the application effect of pharmacists' participation in the maintenance and manage-ment of smart pharmaceutical platform.Methods The prescriptions of Shunde Hospital of Guangzhou University of Chinese Med-icine from January 2023 to June 2024 were divided into blank group(from January 2023 to March 2023,305 411 traditional man-ual prescriptions were reviewed)and control group(from January 2024 to March 2024).The original rule review of the smart pharmacy platform system was adopted,339 042 copies),and the experimental group(from April 2024 to June 2024,the rule review after pharmacists participated in maintenance management was adopted,317 902 copies).The prescription qualification rate,the proportion of unreasonable prescriptions,the false positive rate,the proportion of manual review prescriptions,and the rate of filling prescriptions were evaluated,and the management effectiveness of the three groups was compared.Results The qualified rate of prescription in the experimental group and the control group was 99.52％ and 99.60％,respectively,which were higher than 98.74％ in the blank group,and there was a difference between the experimental group and the control group(P＜0.05).Among the irrational prescription types in the experimental group,the proportion of unsuitable administration route,in-complete clinical diagnosis,unsuitable indications and unsuitable usage and dosage were 16.57％,29.42％,20.55％ and 33.46％,and 23.28％,15.74％,30.38％ and 30.50％ in the control group.There were significant differences between 40.08％,27.11％,19.91％ and 12.9％ in blank group(P＜0.05).The false positive rate and manual prescription review ra-tio of the experimental group were 0.40％ and 0.88％,respectively,lower than 0.70％and 1.10％of the control group,and the prescription return rate of 0.78％ was higher than 0.10％ of the control group(P＜0.05).Conclusion Pharmacists' par-ticipation in the maintenance and management of smart pharmacy platform has high application value and can improve the drug safety of patients.

Objective To systematically review the clinical effects of Shuxuetong and Low-molecular-weight Heparin(LMWH)in patients with deep vein thrombosis (DVT)in lower limbs.Methods The CNKI,Wanfang,VIP,SinoMed,PubMed,EMBASE,and ISI Web of Science databases were electronically searched from inception to February 3th,2017,to collect the randomized clinical trials on the clinical effects of Shuxuetong and LMWH on DVT in lower limbs.Two investigators independently screened the literatures,extracted data and assessed the quality of enrolled studies.All analyses were performed using the Stata 11.0 software.Results Twenty studies involving 1 515 patients were finally included.The meta-analysis results showed that the total effective rate was significantly higher in Shuxuetong group than in LMWH drug control group(RR =1.22,95 ％ CI:1.13-1.32,P ＜ 0.001).The subgroup analysis showed that there was no significant difference in total effective rate between the Shuxuetong alone group and LMWH alone control group(RR =1.05,95％ CI:0.98-1.12,P =0.136).However,the total effective rate was significantly higher in Shuxuetong combined with LMWH group than in LMWH alone control group(RR =1.30,95％CI:1.18-1.44,P ＜ 0.001).Conclusions Shuxuetong combined with LMWH has better clinical effects than do LMWH alone group in treating patients with DVT in lower limbs.